During my brief stay in the People's Republic of China I sought to obtain systematic and reliable information which would enable me to begin to answer the following questions: (1) How are decisions about drug safety, distribution, production levels, and price made and what have been the implicit or explicit trade-offs? (2) How do the pharmaceutical, research, public health, and population bureaucracies interrelate, how is inter-agency co-ordination achieved, and what have been the successes and problems encountered in this regard? (3) How are decisions made to initiate and discontinue research? (4) How extensive has decentralization of drug research and pharmaceutical production become in the post-Cultural Revolution period? If decentralization has occurred, what tangible consequences has it had? (5) What mechanisms exist to assure public health and environmental quality and what problems have arisen in the process of trying to achieve results in these areas? While there is much that I was unable to learn, if for no other reason than I had no opportunity to meet with relevant government officials, I was able to learn a great deal from the factory managers, researchers, doctors, and administrators with whom I spoke.